Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S26 pseudogene 13 (RPS26P13) is a human pseudogene related to the ribosomal protein S26 gene (RPS26)[2][8]. Unlike the functional RPS26 gene, which encodes a component of the 40S ribosomal subunit implicated in Diamond-Blackfan anemia, RPS26P13 is a processed pseudogene—meaning it is a non-functional DNA sequence with significant similarity to the ancestral protein-coding gene but lacking coding potential and not known to be transcribed or translated into a functional product[2][8]. There are multiple such pseudogenes of ribosomal protein genes found in the genome as a result of evolutionary duplication events[1].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S26 pseudogene 13 (RPS26P13).